Table 4 Longitudinal comparison of TG levels and the correlation with disease severity in HTG-AP patients
Variable | HTG-AP patients, N = 165 | P value | |||
|---|---|---|---|---|---|
24 h | 48 h | 3-4 d | 5-7 d | ||
TG, median (IQR), mg/dL | 2408.8 (1428.8-4785.0) | 921.2 (604.9-1558.4) | 461.9 (315.5-674.4) | 302.7 (229.2-434.5) | < 0.001 |
  > 500, N(%) | 165 (100) | 137 (83.0) | 73 (44.2) | 28 (17.0) | < 0.001 |
  > 1000,N(%) | 148 (89.7) | 76 (46.1) | 15 (9.1) | 1 (0.6) | < 0.001 |
MAP (n = 86) | 1943.8 (1117.5-2689.2) | 797.4 (513.5-1511.7) | 402.7 (289.6-632.5) | 294.3 (216.8-404.0) |  |
MSAP (n = 57) | 3078.8 (2068.6-5713.3) | 938.1 (755.3-1578.8) | 494.7 (317.3-650.0) | 321.2 (245.1-472.6) | |
SAP (n = 22) | 5118.2 (2764.2-7072.6) | 1300.5 (890.2-1752.3) | 650.9 (396.5-899.1) | 338.1 (230.6-481.9) | |
Correlation of TG and disease severity | 0.407* | 0.209* | 0.200* | 0.115 | Â |